Nordic treatment guidelines for rare epileptic conditions: A literature review.

The onset of severe, drug-resistant seizures in early childhood is characteristic of the rare epileptic disorders Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), and CDKL5 deficiency disorder (CDD) and is frequently observed in the rare genetic conditions tuberous sclerosis complex (TSC) and Re...

Full description

Bibliographic Details
Main Authors: Vyas, Kishan, Luedke, Hannah, Ruban-Fell, Benjamin
Format: Article in Journal/Newspaper
Language:English
Published: Wiley 2022
Subjects:
CDKL5 deficiency disorder
Lennox-Gastaut syndrome
Rett syndrome
myoclonic epilepsies
practice guidelines
tuberous sclerosis complex
Norway
Iceland
Online Access:https://doi.org/10.1002/brb3.2622
https://pubmed.ncbi.nlm.nih.gov/35765698
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304844/
Description
Summary:The onset of severe, drug-resistant seizures in early childhood is characteristic of the rare epileptic disorders Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), and CDKL5 deficiency disorder (CDD) and is frequently observed in the rare genetic conditions tuberous sclerosis complex (TSC) and Rett syndrome (RTT). High-quality treatment guidelines are needed for optimal management of these conditions. This review aimed to assess content, availability, and development of treatment guidelines for these disorders in the Nordics region (Denmark, Finland, Iceland, Norway, and Sweden).

Similar Items